直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
  • 最新情報
  • Finneganについて
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • プロボノ活動
  • 事務所運営管理
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Boston Law Firms Among Most Active for New-drug Lawsuits

May 8, 2017

Boston Business Journal

A recent Lex Machina report examined which law firms handle the most lawsuits related to abbreviated new drug applications (ANDA) before the U.S. Food and Drug Administration. The report found that intellectual property law firms with ties to Boston ranked high on the list of firms that have filed the most ANDA suits on behalf plaintiffs. Finnegan, which has an office in Boston, ranked second nationwide with 363 cases since 2009.

Tags

Food and Drug Administration (FDA)

Related Practices

グローバルな知的財産権利の執行、訴訟、および裁判

Related Industries

製薬

Related News

Commentary

East Texas Reclaims Its Patent Crown

August 21, 2026

Media Mention

Law360's Legal Lions of the Week: Volkswagen Group of America, Inc.

August 21, 2026

Commentary

Early Test of USPTO's Ex Parte Preorder Filing Leads to Re-Exam Denial

August 21, 2026

Award/Ranking

31 Finnegan Attorneys Recognized by Best Lawyers 2027

August 20, 2026

Press Release

USPTO Denies Super Lighting Reexamination Request Following PVTECH Pre-Order Submission Under New USPTO Procedure

August 19, 2026

Media Mention

VW Wins in Patent Appeal Over Electrically Controlled Glasses

August 19, 2026

Commentary

Why Global IP Litigants Keep Turning to English Courts

August 19, 2026

Press Release

Federal Circuit Overrules Precedent En Banc in Finnegan Pro Bono Victory for Federally Employed Veterans

August 18, 2026

Commentary

Fed. Circ. Overrules Precedent on Veteran Hiring Protections

August 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP